• Head of Life Sciences Practice.
  • Expert in both national and international law regarding pharmaceuticals, medical devices and innovative technologies.
  • Mainly advises life sciences entities on regulatory requirements, market access, and competition and compliance issues.
  • Represents clients in proceedings before administrative authorities, particularly the Minister of Health and units subordinate to the Minister, and also at the stage of court control of decisions.
  • In the years 2014-2016, he worked in the legal department of the European Medicines Agency, where he co-created EU regulatory practice and soft laws for the life sciences sector. He has represented Poland at the European Commission in working groups and standing committees.
  • For many years, he also gained experience in domestic administration at the Ministry of Health and the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, where he held various positions, including department director.
  • Author and co-author of numerous publications on pharmaceutical law, including a commentary on the Reimbursement Act.
  • Member of the Warsaw Bar Association.

related articles

MIT Global Startup Workshop 2025

News | 24.03.2025

Mateusz Mądry, Marek Paluch, and Maciej Zajda will participate in the conference organized by the Massachusetts Institute of Technology, which will be held in Poland for the first time.

MIT Global Startup Workshop 2025

Event | 24.03.2025

Mateusz Mądry, Marek Paluch, and Maciej Zajda will participate in the conference organized by the Massachusetts Institute of Technology, which will be held in Poland for the first time.

Top Trends Life Sciences 2025 Report

News | 12.03.2025

Our experts have prepared a report summarizing the key issues discussed at the DZP conference on upcoming regulatory changes and challenges in the pharmaceutical industry.